BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4746319)

  • 41. [Plasma elimination, hepatic uptake and biliary excretion of tritiated cardiac glycosides by the isolated perfused liver].
    Kolenda KD; Peters T; Seiler KU
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):375-6. PubMed ID: 4253810
    [No Abstract]   [Full Text] [Related]  

  • 42. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P
    Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.
    Lüllmann H; van Zwieten PA
    J Pharm Pharmacol; 1969 Jan; 21(1):1-8. PubMed ID: 4388183
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of the enterohepatic circulation after 3 H-digoxin administration in the rat.
    Abshagen U; von Bergmann K; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(1):1-10. PubMed ID: 4264167
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative studies on the uptake of cardiac glycosides by the cell].
    Hüsten J; Ruiz-Torres A
    Verh Dtsch Ges Inn Med; 1969; 75():396-9. PubMed ID: 5400163
    [No Abstract]   [Full Text] [Related]  

  • 46. The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and by isolated sarcoplasmic reticulum.
    Dutta S; Goswami S; Datta DK; Lindower JO; Marks BH
    J Pharmacol Exp Ther; 1968 Nov; 164(1):10-21. PubMed ID: 4235402
    [No Abstract]   [Full Text] [Related]  

  • 47. Intestinal absorption of 3H-ouabain: demonstration of a nonsaturable transport process.
    Caldwell JH; Halpin TC; Greenberger NJ
    J Lab Clin Med; 1970 Jan; 75(1):43-52. PubMed ID: 5410498
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
    Reissell P; Manninen V
    Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cardiac glycosides].
    Sova J
    Vnitr Lek; 1975 Jun; 21(6):605-15. PubMed ID: 1136209
    [No Abstract]   [Full Text] [Related]  

  • 50. The rate of uptake of cardiac glycosides into human cultured cells and the effects of chloroquine on it.
    Algharably N; Owler D; Lamb JF
    Biochem Pharmacol; 1986 Oct; 35(20):3571-81. PubMed ID: 2945566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On the problem of cardiac glycoside accumulation].
    Kuschinsky K
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2344-7. PubMed ID: 4881347
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comulative behavior of various cardiac glycosides in anuria].
    Kramer P; Horenkamp J; Willms B; Scheler F
    Dtsch Med Wochenschr; 1970 Feb; 95(9):444-50 passim. PubMed ID: 5412382
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative study of thin-layer chromatographic techniques for separation of digoxin, digitoxin and their main metabolites.
    Carvalhas ML; Figueira MA
    J Chromatogr; 1973 Nov; 86(1):254-60. PubMed ID: 4765314
    [No Abstract]   [Full Text] [Related]  

  • 54. [Correction of the incorrectly measured Hatcher-Brody optimal titer of cardiotonic steroids. Determination of the molar optimal titer at long survival time].
    Vogel G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):320. PubMed ID: 4242454
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of submicrogram amounts of digoxin, digitoxin, and their metabolic products. Isolation by chromatography and preparation of derivatives for assay by electron capture detector.
    Watson E; Tramell P; Kalman SM
    J Chromatogr; 1972 Jun; 69(1):157-63. PubMed ID: 5039625
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle.
    Kuschinsky K; Lüllmann H; van Zwieten PA
    Br J Pharmacol Chemother; 1968 Mar; 32(3):598-608. PubMed ID: 5641952
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cumulative effect of cardiac glycosides. (Review)].
    Angarskaia MA; Liubartseva LA; Sokolova VE
    Farmakol Toksikol; 1969; 32(6):745-6. PubMed ID: 4909670
    [No Abstract]   [Full Text] [Related]  

  • 58. A morphological study on the myocardial fine structure and the distribution of cardiac glycoside in the myocardium of the failing heart of rabbits.
    Maeda K
    Jpn Circ J; 1973 Aug; 37(8):957-69. PubMed ID: 4800825
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study on the membrane permeability of cardiac using drugs (g-Strophantin, Digoxin and Oxyfedrin) micro-autoradiography in guinea pig heart].
    Löhr E; Makoski HB; Göbbeler T; Strötges MW
    Arzneimittelforschung; 1971 Jul; 21(7):921-7. PubMed ID: 5109500
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.